Nanotechnology, Science and Applications

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Nanotechnology, Science and Applications on "Advancing Novel Nanozymes: Preparation, Performance Analysis, and Functional Application Design", organized by Dr. Amin Zhang (Shanghai Jiao Tong University, China), Dr. Qian Zhang (Shanghai Jiao Tong University, China) and Dr. Jin Cheng (Wuxi Center for Disease Control and Prevention, China).

Nanozymes, a class of nanomaterials with enzyme-like catalytic properties, have emerged as a ground-breaking innovation in the fields of nanotechnology and biotechnology. These artificial enzymes replicate the catalytic activities of natural enzymes while offering enhanced stability, cost-efficiency, and remarkable potential for multifunctional design. Since their discovery, nanozymes have garnered significant attention due to their versatility, enabling diverse applications in catalysis, biosensing, medicine, and environmental remediation.

The significance of nanozymes lies in their ability to overcome the inherent limitations of natural enzymes, such as their susceptibility to denaturation and high production costs. These challenges are particularly pressing in industries that require robust and reusable catalytic agents, including industrial processing, clinical diagnostics, and therapeutic applications. Moreover, the rapid evolution of nanozyme technologies has paved the way for ground-breaking innovations, such as combating antimicrobial resistance, engineering targeted cancer therapies, and fostering sustainable environmental solutions. By focusing on the preparation, performance optimization, and functional application design of novel nanozymes, this research not only enhances foundational scientific understanding but also delivers practical benefits across a broad spectrum of scientific and industrial domains.

This Article Collection aims to highlight the latest advancements in nanozyme research, covering their preparation, performance evaluation, and innovative applications. The scope includes, but is not limited to:

• Synthetic Strategies: Development of cutting-edge methodologies for nanozyme synthesis, including green and bio-inspired approaches.
• Mechanistic Insights: Elucidation of catalytic mechanisms and exploration of structure-property relationships.
• Biomedical Applications: Deployment of nanozymes in diagnostics, therapeutic interventions, and targeted drug delivery systems.
• Environmental Applications: Applications of nanozymes in pollutant degradation, waste management, and sustainable catalysis.
• Integration in Multifunctional Systems: Design and incorporation of nanozymes into hybrid materials and advanced devices.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 31 December 2025.

Please submit your manuscript on our website, using the promo code ZKKJU for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Advancing Novel Nanozymes: Preparation, Performance Analysis, and Functional Application Design” Collection.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Dr. Amin Zhang, Shanghai Jiao Tong University

[email protected]

Dr. Amin Zhang graduated from Shanghai Jiao Tong University in 2020 with a Ph.D. in Instrument Science and Technology (Biomedical and Engineering track), she finished postdoctoral research there and became an Assistant Researcher at the School of Agriculture and Biology in March 2024. Her research focuses on developing nanozyme sensing technologies and designing functional active component delivery systems. She has published over 30 papers in top international journals, such as Advanced Materials, Biosensors and Bioelectronics, Nano Research, Theranostics, and Sensors and Actuators B: Chemical.

Dr. Qian Zhang, Shanghai Jiao Tong University

[email protected]

Dr. Qian Zhang graduated in 2015 with a Ph.D. in Science from Philipps-Universität Marburg, Germany, under the supervision of Professor Wolfgang J. Parak. From 2016 to 2017, conducted postdoctoral research in Professor Da-Xiang Cui's research group at the School of Electronics. Served as an Assistant Researcher at the same institution from 2018 to 2022 and was promoted to Associate Researcher in 2023. In recent years, she focuses primarily on the controlled synthesis and performance studies of various inorganic nanomaterials and the development of nanodrug delivery systems to achieve multimodal tumor therapy under MRI/NIR guidance. She has published over 50 SCI papers, including 17 as the first or corresponding author, with 3 ESI Highly Cited Papers. These works have been cited more than 3,200 times, with an H-index of 29. Additionally, the applicant has contributed to two books (in both Chinese and English) and holds three authorized patents.

Dr. Jin Cheng, Wuxi Center for Disease Control and Prevention

[email protected]

Dr. Jin Cheng graduated from Shanghai Jiao Tong University in 2021 with a Ph.D. in Instrument Science and Technology (Biomedical and Engineering track). Since July 2021, serves as an Assistant Researcher at the Wuxi Center for Disease Control and Prevention. His research focuses on DNA nanotechnology, tumor therapy, and disease diagnosis and detection. He has published over 20 papers in top international journals like Angewandte Chemie International Edition, Nature Communications, and Nanoscale.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Nanotechnology, Science and Applications on "Current Advances in Nanotechnology: Prospects and Challenges of Nanotherapeutics in Treating Cancers", organized by Prof. Veena Agrawal (University of Delhi, India).

Cancer is a major health issue globally, with an estimated 20 million new cases and 9.7 million deaths in 2022. By 2050, projections indicate a significant increase to over 35 million new cases. Discovering novel medicines is an urgent need. Nanomedicine has emerged as a new multidisciplinary field capturing the attention of scientists. Nanotherapeutics have capabilities for effectively transporting medicines or gene fragments to tumor tissues via passive or active targeting processes; thus there are immense possibilities for enhancing treatment outcomes while causing minimum harm to healthy tissues. Nanoparticles can also be employed for advanced imaging techniques, such as MRI and PET scans, providing better visualization of internal organs and tissues. The engineered nanoparticles can be employed as contrast agents in cancer diagnostics to enable high sensitivity and high-resolution imaging examinations and tumor detection. Novel approaches for tumor labeling and detection are also made possible by the use of nanoprobes. While nanotechnology shows great potential, clinical translation faces challenges related to biocompatibility, toxicity, and the complexity of the tumor microenvironment.

Nanotechnology holds great potential where it enables targeted drug delivery, development of nano-biosensors for early disease detection, and advanced imaging techniques such as MRI and PET scans. Nanoparticles can be designed for improved cancer detection, and enhanced immune responses. Nanoparticles can be employed in the context of radiation sensitization and photothermal therapy to enhance the therapeutic efficacy of malignant tumors. The combination of nanotechnology and conventional tumor therapy can not only enhance the properties of chemoradiotherapy drugs but also reduce the incidence of poisoning and other side effects. These NPs can rapidly cross the human biological barriers, even in a targeted manner and continuously release the content to maintain the appropriate blood concentration of the drug.

Potential subtopics related to recurrent miscarriage include (but are not limited to):

• Bio/molecular nanosystems, nanoparticles including nanoscale bio/therapeutics and nano drug carriers, extracellular vesicles, smart and stimuli responsive nanobiosystems
• Nanotoxicity, nanotoxicology, biomedical sensors including sensor fusion
• Nanomedicine
• Gene therapy
• Biomimetic nanoengineering
• Single particle and single cell analysis, biomedical imaging, nanobiotechnology
• Photothermal therapy
• Nanomedicines in Skin cancer
• Nanomedicines in Lung cancer

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 June 2026.

Please submit your manuscript on our website, using the promo code E639F to indicate that your manuscript will be considered for this Article Collection.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest Advisor

Prof. Veena Agrawal, University of Delhi

[email protected]

Professor Veena Agrawal, Senior Professor (R)of Botany (Level-15), University of Delhi, specializes in medicinal plant biotechnology, nanobiotechnology (green synthesis of nanoparticles and their efficacy against, different cancer cells, malaria vectors and diabetes), isolation and characterization of natural biomolecules, sex-linked molecular markers and genetic diversity analysis. She has published over 125 research articles in leading international journals with high impact factors, including Artificial Cells, Nanomedicines, Material Science and Engineering, Industrial Crops, Plant cell reports, Current Cancer Drug Target, Plant Science, Plant Physiology and Biochemistry, Process safety & Environmental Research, etc., Twenty five Ph. D and 21 M.phil. students obtained their degrees under her supervision in different disciplines. She is a Fellow of the Linnean Society of London (FLS) and a member of many international and national academic societies. She is on the editorial board of many journals including Arti. Cells Nanomedicines and Biotechnology. She is on the expert panels of international/national institutions for reviewing and evaluating research projects and Ph,D. theses. She has immensely contributed research to international and national platforms through presentations at conferences, seminars, and publications, as well as registering patents and receiving many awards and recognitions.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in Nanotechnology, Science and Applications on "Uniting Natural Products and Biotechnology for the Next Generation of Nanomedicine", organized by Dr. Przemysław Sitarek (Medical University of Lodz, Poland) and Dr. Tomasz Kowalczyk (University of Lodz, Poland).

This Article Collection focuses on the convergence of nanotechnology, natural bioactive compounds, and biotechnology to develop advanced therapeutic approaches for a wide range of diseases. The integration of plant-derived phytochemicals, animal-based molecules, and recombinant proteins into nanoscale delivery systems opens new frontiers in precision medicine, offering improved biocompatibility, targeted delivery, and enhanced therapeutic efficacy. Recent advancements in biotechnology have enabled the design and production of engineered proteins and biomolecules with high specificity and functional versatility, further enriching the potential of nanomedical platforms. When combined with the diverse pharmacological properties of naturally sourced compounds, these hybrid nanosystems present promising strategies for treating cancer, infectious diseases, inflammatory conditions, metabolic disorders, and neurodegenerative diseases. This Collection invites original research, reviews, and perspectives that explore the design, synthesis, characterization, and biomedical application of nature-inspired and bioengineered nanostructures. The aim is to provide a multidisciplinary outlook on how the fusion of nanotechnology with natural and recombinant therapeutic agents can drive innovation in diagnosis, treatment, and regenerative medicine.

This Article Collection title encapsulates a timely and significant convergence of nanotechnology, biotechnology, and nature-derived bioactive compounds originating from plant and animal sources. In the context of escalating global health challenges—such as cancer, antimicrobial resistance, chronic inflammation, and neurodegenerative disorders—there is a pressing demand for the development of therapeutic strategies that are not only safe and effective, but also precisely targeted.

Natural molecules exhibit potent biological activity and favorable biocompatibility; however, their clinical potential is often limited by low stability and bioavailability. Advances in biotechnology and nanocarrier systems offer powerful tools to overcome these limitations by enhancing molecular stability, enabling controlled delivery, and improving therapeutic precision. The incorporation of recombinant proteins further broadens the therapeutic arsenal, supporting the design of personalized and multifunctional treatment modalities.

This title reflects the essence of an interdisciplinary approach that synergistically integrates nature’s pharmacological potential with the precision and adaptability of modern scientific innovation. It signals the emergence of a new era in nanomedicine—one in which nanoscale and molecular-level technologies converge to yield next-generation solutions for complex and treatment-resistant diseases.

Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 June 2026.

Please submit your manuscript on our website, using the promo code F4163 to indicate that your manuscript will be considered for this Article Collection.

Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

Guest Advisors

Dr. Przemysław Sitarek, Medical University of Lodz

[email protected]

Przemysław Sitarek is an Associate Professor at the Medical University of Łódź (Poland), where he heads the Department of Medical Biology at the Faculty of Pharmacy. His interdisciplinary research spans biotechnology and nanotechnology, with a strong focus on biologically active compounds, recombinant proteins, and metabolic engineering. He is particularly interested in investigating metabolic pathways and developing nature-inspired biomedical solutions to address contemporary therapeutic challenges. His work contributes to advancing the role of both natural and engineered molecules in next-generation nanomedicine.

Dr. Tomasz Kowalczyk, University of Lodz

[email protected]

Tomasz Kowalczyk, PhD, is an assistant professor in the Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Łódź and Department of Medical Biology, Faculty of Pharmacy, Medical University of Lodz. Research interests: Biotechnological production of natural biologically active compounds from plant and other natural sources Development of plant-based and microbial expression systems for production of valuable secondary metabolites and recombinant proteins Application of nanotechnology in combination with biotechnology.

View all papers in this article collection

Editor-in-Chief: Professor Kattesh V Katti